XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Business Segments | 3 Months Ended
--- | ---
Mar. 31, 2024
Segment Reporting [Abstract] |
Business Segments | Business Segments The Company's property and casualty commercial insurance operations are managed and reported in three business segments: Specialty, Commercial and International. These three segments are collectively referred to as Property & Casualty Operations. The Company's operations outside of Property & Casualty Operations are managed and reported in two segments: Life & Group and Corporate & Other. The accounting policies of the segments are the same as those described in Note A to the Consolidated Financial Statements within CNAF's Annual Report on Form 10-K for the year ended December 31, 2023. The Company manages most of its assets on a legal entity basis, while segment operations are generally conducted across legal entities. As such, only Insurance and Reinsurance receivables, Insurance reserves, Deferred acquisition costs, Goodwill and Deferred non-insurance warranty acquisition expense and revenue are readily identifiable for individual segments. Distinct investment portfolios are not maintained for every individual segment; accordingly, allocation of assets to each segment is not performed. Therefore, a significant portion of Net investment income and Net investment gains or losses are allocated primarily based on each segment's net carried insurance reserves, as adjusted. All significant intersegment income and expense have been eliminated. Income taxes have been allocated on the basis of the taxable income of the segments. In the following tables, certain financial measures are presented to provide information used by management to monitor the Company's operating performance. Management utilizes these financial measures to monitor the Company's insurance operations and investment portfolio. The performance of the Company's insurance operations is monitored by management through core income (loss), which is derived from certain income statement amounts. The Company's investment portfolio is monitored by management through analysis of various factors including unrealized gains and losses on securities, portfolio duration and exposure to market and credit risk. Core income (loss) is calculated by excluding from net income (loss) the after-tax effects of net investment gains or losses. The calculation of core income (loss) excludes net investment gains or losses because net investment gains or losses are generally driven by economic factors that are not necessarily reflective of our primary operations. The Company's results of operations and selected balance sheet items by segment are presented in the following tables.
Three months ended March 31, 2024 | Specialty |  | Commercial |  | International |  | Life & Group |  | Corporate & Other |  |  |  |
(In millions) |  |  |  |  |  | Eliminations |  | Total
Operating revenues |  |  |  |  |  |  |  |  |  |  |  |  |
Net earned premiums | $ | 814 |  |  | $ | 1,202 |  |  | $ | 315 |  |  | $ | 110 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,441 |
Net investment income | 150 |  |  | 176 |  |  | 31 |  |  | 231 |  |  | 21 |  |  | — |  |  | 609 |
Non-insurance warranty revenue | 407 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 407 |
Other revenues | 1 |  |  | 8 |  |  | — |  |  | — |  |  | 3 |  |  | (3) |  |  | 9 |
Total operating revenues | 1,372 |  |  | 1,386 |  |  | 346 |  |  | 341 |  |  | 24 |  |  | (3) |  |  | 3,466 |
Claims, benefits and expenses |  |  |  |  |  |  |  |  |  |  |  |  |
Net incurred claims and benefits | 477 |  |  | 828 |  |  | 189 |  |  | 312 |  |  | (8) |  |  | — |  |  | 1,798 |
Policyholders’ dividends | 2 |  |  | 7 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 9 |
Amortization of deferred acquisition costs | 178 |  |  | 200 |  |  | 66 |  |  | — |  |  | — |  |  | — |  |  | 444 |
Non-insurance warranty expense | 394 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 394 |
Other insurance related expenses | 81 |  |  | 138 |  |  | 39 |  |  | 29 |  |  | — |  |  | — |  |  | 287 |
Other expenses | 15 |  |  | 12 |  |  | 2 |  |  | — |  |  | 59 |  |  | (3) |  |  | 85 |
Total claims, benefits and expenses | 1,147 |  |  | 1,185 |  |  | 296 |  |  | 341 |  |  | 51 |  |  | (3) |  |  | 3,017 |
Core income (loss) before income tax | 225 |  |  | 201 |  |  | 50 |  |  | — |  |  | (27) |  |  | — |  |  | 449 |
Income tax (expense) benefit on core income (loss) | (48) |  |  | (43) |  |  | (13) |  |  | 5 |  |  | 5 |  |  | — |  |  | (94) |
Core income (loss) | $ | 177 |  |  | $ | 158 |  |  | $ | 37 |  |  | $ | 5 |  |  | $ | (22) |  |  | $ | — |  |  | 355 |
Net investment gains (losses) |  |  |  |  |  |  |  |  |  |  |  |  | (22) |
Income tax (expense) benefit on net investment gains (losses) |  |  |  |  |  |  |  |  |  |  |  |  | 5 |
Net investment gains (losses), after tax |  |  |  |  |  |  |  |  |  |  |  |  | (17) |
Net income (loss) |  |  |  |  |  |  |  |  |  |  |  |  | $ | 338 |
March 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |
(In millions) |  |  |  |  |  |  |  |  |  |  |  |  |
Reinsurance receivables | $ | 1,432 |  |  | $ | 1,279 |  |  | $ | 477 |  |  | $ | 92 |  |  | $ | 2,316 |  |  | $ | — |  |  | $ | 5,596 |
Insurance receivables | 979 |  |  | 2,096 |  |  | 379 |  |  | 4 |  |  | — |  |  | — |  |  | 3,458 |
Deferred acquisition costs | 401 |  |  | 394 |  |  | 132 |  |  | — |  |  | — |  |  | — |  |  | 927 |
Goodwill | 117 |  |  | — |  |  | 29 |  |  | — |  |  | — |  |  | — |  |  | 146 |
Deferred non-insurance warranty acquisition expense | 3,621 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 3,621 |
Insurance reserves |  |  |  |  |  |  |  |  |  |  |  |  |
Claim and claim adjustment expenses | 7,221 |  |  | 10,332 |  |  | 2,745 |  |  | 663 |  |  | 2,627 |  |  | — |  |  | 23,588 |
Unearned premiums | 3,193 |  |  | 2,996 |  |  | 740 |  |  | 118 |  |  | — |  |  | (1) |  |  | 7,046 |
Future policy benefits | — |  |  | — |  |  | — |  |  | 13,513 |  |  | — |  |  | — |  |  | 13,513 |
Deferred non-insurance warranty revenue | 4,645 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4,645 |
Three months ended March 31, 2023 | Specialty |  | Commercial |  | International |  | Life & Group |  | Corporate & Other |  |  |  |
(In millions) |  |  |  |  | Eliminations |  | Total
Operating revenues |  |  |  |  |  |  |  |  |  |  |  |  |
Net earned premiums | $ | 797 |  |  | $ | 1,046 |  |  | $ | 290 |  |  | $ | 115 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,248 |
Net investment income | 129 |  |  | 149 |  |  | 23 |  |  | 214 |  |  | 10 |  |  | — |  |  | 525 |
Non-insurance warranty revenue | 407 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 407 |
Other revenues | — |  |  | 7 |  |  | — |  |  | — |  |  | 3 |  |  | (3) |  |  | 7 |
Total operating revenues | 1,333 |  |  | 1,202 |  |  | 313 |  |  | 329 |  |  | 13 |  |  | (3) |  |  | 3,187 |
Claims, benefits and expenses |  |  |  |  |  |  |  |  |  |  |  |  |
Net incurred claims and benefits | 465 |  |  | 688 |  |  | 189 |  |  | 311 |  |  | (7) |  |  | — |  |  | 1,646 |
Policyholders’ dividends | 1 |  |  | 6 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 7 |
Amortization of deferred acquisition costs | 165 |  |  | 169 |  |  | 45 |  |  | — |  |  | — |  |  | — |  |  | 379 |
Non-insurance warranty expense | 384 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 384 |
Other insurance related expenses | 86 |  |  | 142 |  |  | 47 |  |  | 29 |  |  | 1 |  |  | — |  |  | 305 |
Other expenses | 14 |  |  | 6 |  |  | 1 |  |  | 1 |  |  | 41 |  |  | (3) |  |  | 60 |
Total claims, benefits and expenses | 1,115 |  |  | 1,011 |  |  | 282 |  |  | 341 |  |  | 35 |  |  | (3) |  |  | 2,781 |
Core income (loss) before income tax | 218 |  |  | 191 |  |  | 31 |  |  | (12) |  |  | (22) |  |  | — |  |  | 406 |
Income tax (expense) benefit on core income (loss) | (47) |  |  | (40) |  |  | (7) |  |  | 9 |  |  | 4 |  |  | — |  |  | (81) |
Core income (loss) | $ | 171 |  |  | $ | 151 |  |  | $ | 24 |  |  | $ | (3) |  |  | $ | (18) |  |  | $ | — |  |  | 325 |
Net investment gains (losses) |  |  |  |  |  |  |  |  |  |  |  |  | (35) |
Income tax (expense) benefit on net investment gains (losses) |  |  |  |  |  |  |  |  |  |  |  |  | 7 |
Net investment gains (losses), after tax |  |  |  |  |  |  |  |  |  |  |  |  | (28) |
Net income (loss) |  |  |  |  |  |  |  |  |  |  |  |  | $ | 297 |
December 31, 2023 |  |  |  |  |  |  |  |  |  |  |  |  |
(In millions) |  |  |  |  |  |  |  |  |  |  |  |  |
Reinsurance receivables | $ | 1,281 |  |  | $ | 1,218 |  |  | $ | 468 |  |  | $ | 93 |  |  | $ | 2,374 |  |  | $ | — |  |  | $ | 5,434 |
Insurance receivables | 1,053 |  |  | 2,024 |  |  | 388 |  |  | 5 |  |  | — |  |  | — |  |  | 3,470 |
Deferred acquisition costs | 392 |  |  | 371 |  |  | 133 |  |  | — |  |  | — |  |  | — |  |  | 896 |
Goodwill | 117 |  |  | — |  |  | 29 |  |  | — |  |  | — |  |  | — |  |  | 146 |
Deferred non-insurance warranty acquisition expense | 3,661 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 3,661 |
Insurance reserves |  |  |  |  |  |  |  |  |  |  |  |  |
Claim and claim adjustment expenses | 7,131 |  |  | 10,103 |  |  | 2,709 |  |  | 675 |  |  | 2,686 |  |  | — |  |  | 23,304 |
Unearned premiums | 3,227 |  |  | 2,858 |  |  | 749 |  |  | 99 |  |  | — |  |  | — |  |  | 6,933 |
Future policy benefits | — |  |  | — |  |  | — |  |  | 13,959 |  |  | — |  |  | — |  |  | 13,959 |
Deferred non-insurance warranty revenue | 4,694 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4,694 |
The following table presents operating revenues by line of business for each reportable segment.
Three months ended March 31 |  |  |
(In millions) | 2024 |  | 2023
Specialty |  |  |
Management & Professional Liability | $ | 729 |  |  | $ | 705 |
Surety | 182 |  |  | 168 |
Warranty & Alternative Risks | 461 |  |  | 460 |
Specialty revenues | 1,372 |  |  | 1,333 |
Commercial |  |  |
Middle Market | 432 |  |  | 398 |
Construction | 455 |  |  | 385 |
Small Business | 154 |  |  | 150 |
Other Commercial | 345 |  |  | 269 |
Commercial revenues | 1,386 |  |  | 1,202 |
International |  |  |
Canada | 98 |  |  | 93 |
Europe | 143 |  |  | 127 |
Hardy | 105 |  |  | 93 |
International revenues | 346 |  |  | 313 |
Life & Group revenues | 341 |  |  | 329 |
Corporate & Other revenues | 24 |  |  | 13 |
Eliminations | (3) |  |  | (3) |
Total operating revenues | 3,466 |  |  | 3,187 |
Net investment gains (losses) | (22) |  |  | (35) |
Total revenues | $ | 3,444 |  |  | $ | 3,152 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//280/tableOfContent Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration